Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand

BACKGROUND: Non-squamous non-small cell lung cancer (NSCLC) patients with Epidermal Growth Factor Receptor (EGFR) mutation benefit from targeted treatments. Previous studies reported EGFR mutation-positive proportions among tested non-squamous NSCLC patients. However, incidence rates and population...

Descripción completa

Detalles Bibliográficos
Autores principales: Aye, Phyu Sin, McKeage, Mark James, Tin Tin, Sandar, Khwaounjoo, Prashannata, Elwood, J Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104366/
https://www.ncbi.nlm.nih.gov/pubmed/33961689
http://dx.doi.org/10.1371/journal.pone.0251357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104366/
https://www.ncbi.nlm.nih.gov/pubmed/33961689
http://dx.doi.org/10.1371/journal.pone.0251357

Ejemplares similares